Jason Duncan Albireo Pharma, Inc. (ALBO) insider trading activity

ALBO Quotes by TradingView

Jason Duncan is Chief Legal Officer and GC of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Jan 21, 2021, when has been sold 5,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jason Duncan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2021
BUY
Grant, award, or other acquisition
-
5,500 Added 36.81%
9,442 Common Stock
Oct 22 2020
SELL
Open market or private sale
$3,089 $34.71 p/Share
89 Reduced 2.3%
3,781 Common Stock

Also insider at

NMRA
Neumora Therapeutics, Inc.
Chief Legal Officer
JD

Jason Duncan

Chief Legal Officer and GC
Boston, MA

Track Institutional and Insider Activities on ALBO

Follow ALBIREO PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALBO shares.

Notify only if

Insider Trading

Get notified when an Albireo Pharma, Inc. insider buys or sells ALBO shares.

Notify only if

News

Receive news related to ALBIREO PHARMA, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALBO